AbbVie
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $15,002,000 | $16,618,000 | $15,776,000 | $15,423,000 |
Gross Profit | 10,784,000 | 12,066,000 | 10,472,000 | 11,077,000 |
EBITDA | 3,692,000 | 5,369,000 | 3,516,000 | 4,344,000 |
EBIT | 1,756,000 | 3,382,000 | 1,453,000 | 2,294,000 |
Net Income | 699,000 | 1,816,000 | 186,000 | 938,000 |
Net Change In Cash | 15,002,000 | 16,618,000 | 15,776,000 | 15,423,000 |
Free Cash Flow | 3,564,000 | 4,889,000 | 7,528,000 | 4,884,000 |
Cash | 9,391,000 | 5,229,000 | 5,629,000 | 6,467,000 |
Basic Shares | 1,774,000 | 1,774,000 | 1,772,000 | 1,772,000 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $61,160,000 | $56,334,000 | $54,318,000 | $58,054,000 |
Gross Profit | 42,956,000 | 39,430,000 | 33,903,000 | 40,640,000 |
EBITDA | 17,629,000 | 14,910,000 | 17,172,000 | 24,174,000 |
EBIT | 9,490,000 | 6,524,000 | 8,474,000 | 15,707,000 |
Net Income | 4,226,000 | 4,278,000 | 4,863,000 | 11,836,000 |
Net Change In Cash | 61,160,000 | 56,334,000 | 54,318,000 | 58,054,000 |
Cost of Revenue | -483,000 | |||
Free Cash Flow | 17,816,000 | 17,832,000 | 22,062,000 | 24,248,000 |
Cash | 5,229,000 | 5,524,000 | 12,814,000 | 9,201,000 |
Basic Shares | 1,774,000 | 1,773,000 | 1,773,000 | 1,778,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $2.65 |
2025-12-31 | $2.71 |
2025-09-30 | $1.86 |
2025-06-30 | $2.97 |